Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A rare, harmless hair condition was found in an infant's eyebrow, needing no treatment.

Recognizing eyebrow hair loss linked to a rare skin condition is crucial for proper treatment.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A 4-year-old girl has a rare condition causing hairlessness and skin bumps, but normal teeth and sweating.

Trichorrhexis invaginata can occur with tinea capitis, though it's rare.

A young man had a rare skin condition causing hair loss and forehead lesions.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Acneiform follicular mucinosis can be controlled with systemic corticosteroids.

Scalp abscesses can occur after hair loss treatments and may be caused by Mycobacterium abscessus.

Permanent hair removal with lasers may cure itchy black hair bristles on the back.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Inflammation may play a role in causing androgenetic alopecia.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Early diagnosis and personalized treatment can prevent damage from dissecting cellulitis after hair restoration surgery.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.